H.R. 1’s limits on Medicaid eligibility for certain immigrants -- a provision the National Association of Medicaid Directors head worried hasn't been publicly discussed enough and that beneficiary ...

Log in to access this content.

As several pharmacy benefit manager reform bills move through Congress, the top PBM lobby is leveraging a new government report to refute criticism that PBM-owned pharmacies under Medicare Part D ...

A flurry of activity related to the recently redubbed CHOICE plans continues as the White House Office of Management and Budget is now reviewing a proposed rule that aims to expand employer’s ability ...

As HHS increasingly integrates AI into internal systems and government health programs, a pair of bipartisan senators are reintroducing the Transparent Automated Governance Act that would require the ...

CMS released Thursday (Oct. 8) the 2027 Star Ratings for Medicare Advantage and Part D plans, announcing about 37% of MA-prescription drug contracts offered in 2027 will have four or more stars and, ...

The Advanced Research Projects Agency for Health (ARPA-H) announced prize winners last month that collectively will receive $87 million for a new program intended to develop methods to produce, store ...

The much-anticipated final rule updating requirements for insurers and group health plans to publish negotiated prices has cleared the White House Office of Management and Budget.

A new benchmark system designed to measure and track the structural fragility of the nation’s drug supply chain shows more than 550 million prescriptions were filled in 2023 for medicines with high or ...

The Trump administration finalized updates to its Transparency in Coverage (TIC) rule Monday (Oct. 5), requiring health plans and insurers to publish more usable pricing data and attest to its ...

A new AARP report analyzes the tactics AstraZeneca used to prevent lower-cost alternatives to its blockbuster inhaler Symbicort from entering the market when the brand drug’s exclusivity period was ...